Re:Effect of early treatment with fluvoxamine on risk of hos...
by cheaprentalyeti on Friday October 29, 2021 @04:39PM
(#29043281)
I used Azithromycin for a reason, because until Covid Brand Viral Pneumonia came along, Azithromycin was considered a standard part of the treatment protocol for viral pneumonia just in case. And because of this study, which I suggest reading carefully. [0].
(And it's funny, that the surgisphere study that showed that HCQ didn't work was published straight away, even though the data was fraudulent? And a similar one that showed that ACE inhibitors didn't work too? They both got published in the Lancet straight away, and noone has any questions about _why_ that was done.)
Re:Effect of early treatment with fluvoxamine on risk of hos...
by ceejayoz on Friday October 29, 2021 @05:09PM
(#29043582)
"Give antibiotics for pneumonia" and "give antiparisitics for pneumonia" are slightly different scenarios, yes?
Re:Effect of early treatment with fluvoxamine on risk of hos...
by cheaprentalyeti on Friday October 29, 2021 @05:18PM
(#29043662)
Well, as was pointed out elsewhere on this thread, 1) earlier this decade ivermectin was being studied for antiviral properties. 2) Azithromycin's use as a covid treatment seems to be controversial, even though a couple years ago it would have been considered a standard treatment for _viral_ pneumonia to combat the _possibility_ of bacterial infection.
Re:Effect of early treatment with fluvoxamine on risk of hos...
by ceejayoz on Friday October 29, 2021 @05:28PM
(#29043760)
> Azithromycin's use as a covid treatment seems to be controversial...
By itself? Or as part of the supposed protocol from HQC/zinc/zpak pushers?
Re:Effect of early treatment with fluvoxamine on risk of hos...
by cheaprentalyeti on Friday October 29, 2021 @05:59PM
(#29044009)
Both in conjunction with HCQ and zinc, in conjunction with other drugs (like the antihistiamine treatment I linked to earlier), and by itself.
The situation is more akin to a few doctors deciding to prescribe azithromycin to schizophrenia patients without much evidence of efficacy, for which they'd be rightly at risk of trouble with their medical licenses.